Psoriasis Care - DermaTherapy® Bedding

REVOLUTIONARY NEW BEDDING DEVELOPED FOR SUFFERERS OF PSORIASIS AND OTHER SENSITIVE SKIN CONDITIONS

The first therapeutic bedding to be approved by the American FDA as a Class 1 Medical Device is now available from Espère Healthcare Ltd.

DermaTherapy® bedding is designed to minimize friction with the skin, unlike cotton and poly-cotton sheets which have microscopic protruding fibres that can irritate the skin, particularly when they become damp.

DermaTherapy® bedding is made from uniquely structured continuous filament yarns that are woven in such a way as to create micro-channels that effectively dissipate heat and wick moisture away from the skin and distribute it evenly over the whole surface of the sheet where it quickly evaporates. This patent-pending new development in fabric technology results in a cleaner, drier and smoother sleeping surface.

DermaTherapy® bedding has a durable antimicrobial treatment permanently bonded into the fabric to help maintain the fabrics freshness and eliminates odours caused by bacteria and fungi PLUS a ‘soil release’ finish to help remove most oils, creams, blood and other stains.

In hospitals and nursing homes DermaTherapy® can withstand the abuse of 90oC washes. However in a household environment a 40oC wash with normal detergents will suffice. These easycare sheets and pillowcases require no fabric conditioner and only a cool tumble dry before they go back on the bed.

Compared to cotton bedding, DermaTherapy sheets are:

• 29% lighter
• 43% thinner
• 53% more supple
• 37% smoother
• Restores dryness in 25 minutes

The development of this fabric technology results in a cleaner, cooler, drier, smoother and more comfortable sleeping surface. For those who suffer from various delicate skin conditions or tend to sweat and over-heat at night – the difference is truly remarkable.

The information contained on this page has been provided by Espère Healthcare Ltd

 

Page created: 17 June 2008